| NCT ID | NCT07225426 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Obesity & Overweight |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-02-04 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-02-04 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine the feasibility of providing personalized incentives for dietary self-monitoring and/or interim weight loss to people enrolled in a weight-loss program
Eligibility Criteria
Inclusion Criteria: 1. Willing to attend virtual baseline and follow-up data collection visits 2. At least 18 years of age 3. Verified obesity as defined as a BMI ≥30 kg/m2 4. Agree to attend 13 biweekly group classes (virtual) delivered by a registered dietitian 5. Agree to review study materials between classes 6. Regular access to an unshared smart phone 7. Reliable access to internet 8. Able to speak and read English 9. Desire to lose weight 10. Able to connect to a video conference call using a smartphone, tablet or computer with a webcam and microphone 11. Ability to download and use Fitbit app daily 12. Have or be willing to create a Gmail address 13. Physical ability to stand on a scale without support Exclusion Criteria: 1. Weight loss of at least 10lbs in the month prior to screening 2. Weight \> 380lbs 3. Currently enrolled or enrolled in the previous month in a clinical, research, or community program focusing on lifestyle change that could affect weight 4. New user of weight loss medication 5. Pregnant, lactating or planning on becoming pregnant during the study 6. History of bariatric procedure or planning to have bariatric procedure in the study timeframe 7. Residing in a nursing home, skilled nursing facility or assisted living facility 8. Impaired hearing 9. Significant dementia, drug or alcohol abuse, or unstable psychiatric illness (e.g., schizophrenia, psychosis) 10. Current treatment for cancer or being treated for cancer (besides basal cell carcinoma or squamous cell) in the last 6 months 11. Use of insulin, sulfonylureas, or meglitinides due to increased risk for hypoglycemia 12. Diuretic medication doses higher than hydrochlorothiazide or chlorthalidone 25 mg daily, furosemide 40 mg daily, torsemide 20 mg daily, bumetanide 1 mg daily, or any use of metolazone; use of potassium-sparing diuretics is acceptable 13. Unstable heart disease in the 6 months prior to screening 14. Chronic kidney disease at stage 4 or higher 15. Exertional chest pain 16. Pain, fainting, or other conditions that prohibit mild/moderate exercise 17. History of ascites requiring paracentesis 18. Inducing vomiting to prevent weight gain or counteract the effects of eating an average of 1 time per week or more in the past 3 months\* 19. Not suitable for study participation due to other reasons at the discretion of the investigators
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07225426 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07225426 currently recruiting?
Yes, NCT07225426 is actively recruiting participants. Contact the research team at corrine.voils@hsc.utah.edu for enrollment information.
Where is the NCT07225426 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT07225426 clinical trial?
NCT07225426 is sponsored by University of Utah. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.